Prestige Consumer Healthcare Inc
PBH61.400USD
+0.940+1.55%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
2.95BMarktkapitalisierung
14.70KGV TTM
mehr Informationen über Prestige Consumer Healthcare Inc Unternehmen
Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
Prestige Consumer Healthcare Inc Informationen
BörsenkürzelPBH
Name des UnternehmensPrestige Consumer Healthcare Inc
IPO-datumFeb 10, 2005
CEOMr. Ronald M. (Ron) Lombardi, CPA
Anzahl der mitarbeiter600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 10
Addresse660 White Plains Rd.
StadtTARRYTOWN
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl10591
Telefon19145246800
Websitehttps://www.prestigebrands.com/
BörsenkürzelPBH
IPO-datumFeb 10, 2005
CEOMr. Ronald M. (Ron) Lombardi, CPA
Führungskräfte von Prestige Consumer Healthcare Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Keine Daten
Nach RegionUSD
Name
Umsatz
Anteil
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
Nach Geschäftsbereich
Nach Region
Keine Daten
Aktionärsstatistik
Aktualisiert: Fri, Oct 17
Aktualisiert: Fri, Oct 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Andere
60.10%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
Andere
60.10%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
66.27%
Investment Advisor/Hedge Fund
30.99%
Research Firm
3.47%
Hedge Fund
1.89%
Pension Fund
1.33%
Individual Investor
1.29%
Sovereign Wealth Fund
1.12%
Family Office
0.61%
Bank and Trust
0.53%
Institutionelle Beteiligung
Aktualisiert: Wed, Oct 1
Aktualisiert: Wed, Oct 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Macquarie Investment Management
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
949.09K
1.93%
+534.84K
+129.11%
Jun 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Thu, Nov 6
Aktualisiert: Thu, Nov 6
Name
Anteil
Invesco Pharmaceuticals ETF
2.51%
Schwab Ariel Opportunities ETF
2.33%
SPDR S&P Pharmaceuticals ETF
2.31%
Invesco S&P SmallCap Health Care ETF
1.95%
Congress SMid Growth ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.73%
iShares U.S. Pharmaceuticals ETF
1.13%
Brandes US Small-Mid Cap Value ETF
0.86%
JPMorgan Active Small Cap Value ETF
0.72%
Invesco S&P SmallCap Low Volatility ETF
0.63%
Mehr Anzeigen
Invesco Pharmaceuticals ETF
Anteil2.51%
Schwab Ariel Opportunities ETF
Anteil2.33%
SPDR S&P Pharmaceuticals ETF
Anteil2.31%
Invesco S&P SmallCap Health Care ETF
Anteil1.95%
Congress SMid Growth ETF
Anteil1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Anteil1.73%
iShares U.S. Pharmaceuticals ETF
Anteil1.13%
Brandes US Small-Mid Cap Value ETF
Anteil0.86%
JPMorgan Active Small Cap Value ETF
Anteil0.72%
Invesco S&P SmallCap Low Volatility ETF
Anteil0.63%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
